China Biotechnology Reagents & Kits Market Size & Outlook
- Root
- Biotechnology
- Biotechnology Reagents & Kits Market Outlook
- Biotechnology
China Biotechnology Reagents Kits Market, 2018-2028 (US$B)
Global Market
Related Markets
Ask Prism AI about the biotechnology reagents & kits market
Get cited answers from GVR research on market growth, segments, regulations and forecasts.
- Source-linked answers
- Market-specific context
- Traceable figures
China biotechnology reagents & kits market highlights
- The China biotechnology reagents & kits market generated a revenue of USD 28.0 billion in 2020 and is expected to reach USD 106.9 billion by 2028.
- The China market is expected to grow at a CAGR of 18.2% from 2021 to 2028.
- In terms of segment, detection kits was the largest revenue generating kit type in 2020.
- Detection Kits is the most lucrative kit type segment registering the fastest growth during the forecast period.
Biotechnology reagents & kits market data book summary
| Market revenue in 2020 | USD 28.0 billion |
| Market revenue in 2028 | USD 106.9 billion |
| Growth rate | 18.2% (CAGR from 2020 to 2028) |
| Largest segment | Detection kits |
| Fastest growing segment | Detection Kits |
| Historical data | 2018 - 2019 |
| Base year | 2020 |
| Forecast period | 2021 - 2028 |
| Quantitative units | Revenue in USD billion |
| Market segmentation | Purification Kits, Amplification Kits, Detection Kits, Isolation Kits |
| Key market players worldwide | Thermo Fisher Scientific Inc, Qiagen NV, New England Biolabs, Illumina Inc, Agilent Technologies Inc, Bio-Rad Laboratories Inc, Merck KGaA, Promega, Takara Bio Inc, LGC Group, Toyobo Co Ltd |
Other key industry trends
- In terms of revenue, China accounted for 8.3% of the global biotechnology reagents & kits market in 2020.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2028.
- In Asia Pacific, China biotechnology reagents & kits market is projected to lead the regional market in terms of revenue in 2028.
- India is the fastest growing regional market in Asia Pacific and is projected to reach USD 106.0 billion by 2028.
Strong government support and various initiatives are factors that increase demand for biotechnology reagents & kits. Made in China 2025 is an overarching Chinese government strategy document that describes China’s strategy to become a powerhouses in various sectors, including biopharmaceuticals and other medical technologies.
Especially for biotechnology, the roadmap aims for licensing 3 to 5 innovative biotech drugs and their companion diagnostic reagents as well as commercialize 30 to 35 new drugs by 2025. The country has listed broad goals of achieving excellent innovative capacity, manufacturing volume, and international competitiveness in pharmaceutical industry by 2025.
A major plan to advance its biotechnology industry is making biotechnology parks. The country is focused on accelerating the biotechnology industry, including the wide-scale development of personalized medicine & innovative drugs, broad use of genomics, and making gene and cell banks.
No credit card required*
Customize the Report
20% free customization
- Include
- Countries, segments, points
- Tailor
- To your product definition
- Extend
- Deeper competitor detail
- Or
- A fully bespoke study
- Turnaround
- 5–10 working days
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Biotechnology Reagents & Kits Market Scope
Biotechnology Reagents Kits Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Merck KGaA | View profile | 62,345 | Frankfurter Strasse 250, Darmstadt, HE, Germany, 64293 | www.emdgroup.com |
| Thermo Fisher Scientific Inc | View profile | 122,000 | 168 Third Avenue, Waltham, MA, United States, 02451 | www.thermofisher.com |
| Illumina Inc | View profile | 9,300 | 5200 Illumina Way, San Diego, CA, United States, 92122 | www.illumina.com |
| Agilent Technologies Inc | View profile | 17,700 | 5301 Stevens Creek Boulevard, Santa Clara, CA, United States, 95051 | www.agilent.com |
| Bio-Rad Laboratories Inc | View profile | 8,030 | 1000 Alfred Nobel Drive, Hercules, CA, United States, 94547 | www.bio-rad.com |
| Qiagen NV | View profile | 5,900 | Hulsterweg 82, Venlo, LI, Netherlands, 5912 PL | www.qiagen.com |
| Takara Bio Inc | View profile | 1,793 | Nojihigashi 7-4-38 Kusatu, Shiga, Otsu, Japan, 520-0058 | www.takara-bio.co.jp |
| LGC Group | View profile | 1001-5000 | Teddington, Gloucestershire, United Kingdom, Europe | www.lgcgroup.com/ |
| Toyobo Co Ltd | View profile | 12,460 | 2-8, Dojima Hama 2-chome, Kita-ku, Osaka, Japan, 530-8230 | www.toyobo.co.jp |
| New England Biolabs | View profile | 501-1000 | Ipswich, Massachusetts, United States, North America | neb.com |
China Biotechnology Reagents & Kits Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Biotechnology Reagents & Kits Market Outlook will help companies and investors design strategic landscapes.
Detection Kits was the largest segment with a revenue share of 22.86% in 2020.
Horizon Databook has segmented the China biotechnology reagents & kits market based on purification kits, amplification kits, detection kits, isolation kits covering the revenue growth of each sub-segment from 2018 to 2028.
Strong government support and various initiatives are factors that increase demand for biotechnology reagents & kits. Made in China 2025 is an overarching Chinese government strategy document that describes China’s strategy to become a powerhouses in various sectors, including biopharmaceuticals and other medical technologies.
Especially for biotechnology, the roadmap aims for licensing 3 to 5 innovative biotech drugs and their companion diagnostic reagents as well as commercialize 30 to 35 new drugs by 2025. The country has listed broad goals of achieving excellent innovative capacity, manufacturing volume, and international competitiveness in pharmaceutical industry by 2025.
A major plan to advance its biotechnology industry is making biotechnology parks. The country is focused on accelerating the biotechnology industry, including the wide-scale development of personalized medicine & innovative drugs, broad use of genomics, and making gene and cell banks.
- China Biotechnology Reagents & Kits Market Kit Type Outlook (Revenue, USD BIllion , 2018-2028)
- Purification Kits
- Amplification Kits
- Detection Kits
- Isolation Kits
- Others
- China Biotechnology Reagents & Kits Market Technology Outlook (Revenue, USD BIllion , 2018-2028)
- LAMP technology
- PCR
- Cell Culture
- Sequencing
- Chromatography
- Electrophoresis
- Flow Cytometry
- Other Technologies
- China Biotechnology Reagents & Kits Market Tested Parameters Outlook (Revenue, USD BIllion , 2018-2028)
- DNA
- RNA
- Enzymes
- Proteins
- Others
- China Biotechnology Reagents & Kits Market Micro-Organisms Outlook (Revenue, USD BIllion , 2018-2028)
- Bacteria
- Virus
- Fungi
- Parasites
- China Biotechnology Reagents & Kits Market Purpose Outlook (Revenue, USD BIllion , 2018-2028)
- On-Site
- Laboratory
- China Biotechnology Reagents & Kits Market End-use Outlook (Revenue, USD BIllion , 2018-2028)
- Healthcare
- Food & Agriculture
- Natural reseources & Environment
- Industrial Processing
- Others
Reasons to subscribe to Biotechnology Reagents & Kits Market Outlook databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Biotechnology Reagents & Kits Market Outlook databook
- Our clientele includes a mix of Biotechnology Reagents & Kits Market Outlook companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the China Biotechnology Reagents & Kits Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into China Biotechnology Reagents & Kits Market Outlook from 2018 to 2028, including revenue numbers, major trends, and company profiles.
China Biotechnology Reagents Kits Market, 2018-2028 (US$B)
China biotechnology reagents & kits market statistics, by kit type, 2018-2028 (USD BIllion)
